Jason Ferrone

Jason has a unique combination of leadership experience across various disciplines of drug discovery and development. Prior to joining Creyon, Jason co-founded Intrinsic Medicine, serving as its President and Chief Operating Officer. At Intrinsic, Jason led regulatory, patent, supply chain and business development strategy as well as helped the company in fundraising and readying the company for a public markets transaction. Jason continues to advise Intrinsic and serves as a member of the board of directors. As he was building Intrinsic, Jason provided intellectual property, regulatory and business strategy consulting services to early-stage drug discovery and development companies. For the preceding nearly 14 years, Jason was at Ionis Pharmaceuticals, where he held various positions including Vice President, Regulatory Affairs and Corporate Development and Vice President, Patents and Corporate Development where he lead the patent group for nearly a decade and served as the Project Team Lead for Ionis’ original PKK drug candidate to treat hereditary angioedema. Before joining Ionis, Jason was patent counsel for Enanta Pharmaceuticals, Inc. and patent manager for the Dana-Farber Cancer Institute. Prior to becoming an attorney, Jason was a research medicinal chemist. Jason received his J.D., cum laude, from Suffolk University Law School, with an Intellectual Property Concentration, his M.A. in Chemistry from San Diego State University, and his B.S. in Biochemistry with an emphasis in Chemistry from the University of California, Riverside.